Takeda Pharmaceutical (TAK) Research & Development (2017 - 2026)

Takeda Pharmaceutical's Research & Development history runs 10 years deep, the most recent figure standing at -$1.2 billion for Q1 2026.

• In Q1 2026, Research & Development rose 12.03% year-over-year to -$1.2 billion; the TTM figure through Mar 2026 stood at -$4.5 billion (up 6.68% YoY), while the FY2026 annual figure was -$4.5 billion, up 6.33% from the prior year.
• Research & Development was -$1.2 billion for Q1 2026 at Takeda Pharmaceutical, down from -$1.1 billion in the prior quarter.
• In the past five years, Research & Development ranged from a high of $8.5 billion in Q1 2024 to a low of -$1.4 billion in Q1 2025.
• Historically, Research & Development has averaged -$611.6 million across 5 years, with a median of -$1.2 billion in 2024.
• The sharpest annual moves came in 2024 and 2025: Research & Development soared 793.43% in 2024, then plunged 116.6% in 2025.
• A 5-year view of Research & Development shows it stood at -$1.2 billion in 2022, then slipped by 2.56% to -$1.3 billion in 2023, then rose by 11.69% to -$1.1 billion in 2024, then fell by 1.71% to -$1.1 billion in 2025, then dropped by 9.38% to -$1.2 billion in 2026.
• The last three Research & Development figures came in at -$1.2 billion (Q1 2026), -$1.1 billion (Q4 2025), and -$1.1 billion (Q3 2025), per Business Quant data.